Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prothrombin Tests Win Coverage Battle, But Payment Hurdles Remain

This article was originally published in The Gray Sheet

Executive Summary

CMS' Sept. 18 coverage decision for prothrombin time self-testing will provide Medicare reimbursement for the disposable test strips, but not the home-use monitoring equipment, according to the Centers for Medicare & Medicaid Services.

You may also be interested in...



St. Jude Looks To Jumpstart Cardiac Surgery Business; CHF Next

St. Jude expects U.S. approval of the Biocor andEpic tissue valves to shore up its declining heart valve business. Launch of the Biocor stented tissue valve is anticipated in the first half of 2004

Prothrombin time self-testing

Payment instructions to local Medicare contractors have been issued, arriving eight months after CMS' coverage decision in September 2001 (1"The Gray Sheet" Oct. 1, 2001, p. 3) and will become effective July 1. Payment levels for procedure code G0249, covering "test materials and equipment," will be released in the July update of the Medicare physician fee schedule...

St. Jude Looks To Jumpstart Cardiac Surgery Business; CHF Next

St. Jude expects U.S. approval of the Biocor andEpic tissue valves to shore up its declining heart valve business. Launch of the Biocor stented tissue valve is anticipated in the first half of 2004

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel